Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

M David Mott

Affiliations

  • Large Shareholder at Mirum Pharmaceuticals Inc. (MIRM), 2019-07-17
  • Large Shareholder, Director at Adaptimmune Therapeutics Plc (ADAP), 2019-07-03
  • Director at Epizyme Inc. (EPZM), 2019-07-02
  • Large Shareholder at Genocea Biosciences Inc. (GNCA), 2019-06-25
  • Large Shareholder, Director at Ardelyx Inc. (ARDX), 2019-06-17
  • Large Shareholder, Director at Mersana Therapeutics Inc. (MRSN), 2019-06-11
  • Large Shareholder, Director at Nightstar Therapeutics Plc (NITE), 2019-06-07
  • Large Shareholder at Trevi Therapeutics Inc. (TRVI), 2019-05-13
  • Large Shareholder at Regulus Therapeutics Inc. (RGLS), 2019-05-09
  • Large Shareholder at Aveo Pharmaceuticals Inc (AVEO), 2019-04-08
  • Large Shareholder, Director at Tesaro Inc. (TSRO), 2019-01-22
  • Large Shareholder at Ra Pharmaceuticals Inc. (RARX), 2018-12-14
  • Large Shareholder at Millendo Therapeutics Inc. (MLND), 2018-12-12
  • Large Shareholder at Phasebio Pharmaceuticals Inc (PHAS), 2018-10-24
  • Large Shareholder at Marker Therapeutics Inc. (MRKR), 2018-10-18
  • Large Shareholder at Elastic N.v. (ESTC), 2018-10-10
  • Large Shareholder at Mulesoft Inc (MULE), 2018-05-09
  • Large Shareholder at Surface Oncology Inc. (SURF), 2018-04-23
  • Large Shareholder at Tracon Pharmaceuticals Inc. (TCON), 2018-03-27
  • Large Shareholder at Cascadian Therapeutics Inc. (CASC), 2018-03-13
  • Large Shareholder at Arca Biopharma Inc. (ABIO), 2018-02-27
  • Large Shareholder at Appian Corp (APPN), 2018-02-15
  • Large Shareholder at Synlogic Inc. (SYBX), 2018-01-26
  • Large Shareholder at Strongbridge Biopharma Plc (SBBP), 2018-01-09
  • Large Shareholder at Arsanis Inc. (ASNS), 2017-11-20
  • Large Shareholder at Care.com Inc (CRCM), 2017-11-09
  • Large Shareholder at Rhythm Pharmaceuticals Inc. (RYTM), 2017-10-10
  • Large Shareholder at Achaogen Inc (AKAO), 2016-12-19
  • Large Shareholder at Roka Bioscience Inc. (ROKA), 2016-09-30
  • Large Shareholder at Interleukin Genetics Inc (ILIU), 2016-08-02
  • Large Shareholder at Cerecor Inc. (CERC), 2015-10-20
  • Large Shareholder at Champions Oncology Inc. (CSBR), 2015-03-24
  • Large Shareholder at Box Inc (BOX), 2015-01-29
  • Large Shareholder at Cvent Inc (CVT), 2014-11-28
  • Large Shareholder at Dermira Inc. (DERM), 2014-10-08
  • Large Shareholder at Loxo Oncology Inc. (LOXO), 2014-08-06
  • Large Shareholder at Aerohive Networks Inc (HIVE), 2014-04-03
  • Large Shareholder at Glycomimetics Inc (GLYC), 2014-01-15
  • Large Shareholder, Director at Omthera Pharmaceuticals Inc. (OMTH), 2013-07-18
  • Large Shareholder at Clovis Oncology Inc. (CLVS), 2013-06-05
  • Large Shareholder at Workday Inc. (WDAY), 2013-04-11
  • Large Shareholder at Millennial Media Inc. (MM), 2012-10-30
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
GNCA $3.50 2,857,142 Large Shareholder 7,225,676 2019-06-24 Filing
TRVI $10.00 1,500,000 Large Shareholder 4,438,562 2019-05-09 Filing
TRVI $10.00 1,000,000 Large Shareholder 2,938,562 2019-05-09 Filing
RGLS $1.08 1,136,704 Large Shareholder 2,052,454 2019-05-07 Filing
AVEO $1.14 4,347,827 Large Shareholder 25,243,865 2019-04-08 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
EPZM $12.43 52,473 Director 0 2019-06-27 Filing
EPZM $12.85 52,472 Director 52,473 2019-06-26 Filing
EPZM $13.31 52,472 Director 104,945 2019-06-25 Filing
ABIO $0.50 1,460,209 Large Shareholder 0 2018-02-26 Filing
APPN $19.49 569,620 Large Shareholder 0 2017-11-27 Filing